Wird geladen...
Benefit of pre-emptive pharmacogenetic information on clinical outcome
The development of new knowledge around the genetic determinants of variable drug action has naturally raised the question of how this new knowledge can be used to improve the outcome of drug therapy. Two broad approaches have been taken: a point-of-care approach in which genotyping for specific var...
Gespeichert in:
| Veröffentlicht in: | Clin Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134843/ https://ncbi.nlm.nih.gov/pubmed/29377064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1035 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|